IVF · INVO Fertility, Inc.
$1.00
-0.03 (-2.91%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.51M
Shares
2.51M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Steven Shum | Chief Executive Officer | $430,863 |
| Terah Krigsvold | Chief Financial Officer | $336,474 |
| Andrea Goren | Chief Business Officer Former Chief Financial Officer | $282,530 |
| Dr. Daniel Teper | Former President | $260,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Steven Shum | Chief Executive Officer | $260,000 |
| Andrea Goren | Chief Financial Officer | $215,000 |
| Mr. Michael Campbell | Former Chief Operating Officer Vice President, Business Development | $192,500 |
| Dr. Daniel Teper | Former President | $137,548 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mr. Michael Campbell | Former Chief Operating Officer Vice President, Business Development | $275,002 |
| Steven Shum | Chief Executive Officer | $232,675 |
| Andrea Goren | Chief Financial Officer | $198,698 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Mr. Michael Campbell | Chief Operating Officer Vice President, Business Development | $1,269,567 |
| Steven Shum | Chief Executive Officer | $402,093 |
| Debra Hoopes | Former Acting Chief Financial Officer | $106,544 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Steven Shum | Chief Executive Officer | $1,347,079 |
| Kathleen Karloff | Former Chief Executive Officer, President (until October 10, 2019) | $526,799 |
| Robert Bowdring | Former Chief Financial Officer ( until August 14, 2019 ) | $365,862 |
| Lori Marzilli-Kahler | — | $185,000 |
| Mr. Michael Campbell | Chief Operating Officer Vice President, Business Development | $171,354 |
| Debra Hoopes | Former Acting Chief Financial Officer | $69,759 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Former VP | Global Operations (until August 31, 2020) | $547,360 |
| Kathleen Karloff | Former Chief Executive Officer, President (until October 10, 2019) | $525,671 |
| Robert Bowdring | Former Chief Financial Officer ( until August 14, 2019 ) | $516,210 |
| Debra Hoopes | Chief Financial Officer (since August 14, 2019) | — |
| Steven Shum | Chief Executive Officer (since October 10, 2019) | — |
| Mr. Michael Campbell | Chief Operating Officer Vice President, Business Development | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Andrea Goren | chief financial officer | Resigned | 2026-01-06 |
| Andrea Goren | chief business officer | Appointed | 2026-01-06 |
| Terah Krigsvold | chief financial officer | Appointed | 2026-01-06 |
| Dr. Daniel Teper | President of the Company | Resigned | 2025-05-30 |
| Lyn Falconio | board of directors | Appointed | 2024-10-15 |
| Daniel Teper | board of directors | Appointed | 2024-10-15 |
| Daniel Teper | President of the Company | Appointed | 2024-10-15 |
| Jeffrey Segal MD | director | Resigned | 2023-04-04 |
| Andrea Goren | Chief Financial Officer | Appointed | 2021-06-15 |
| Andrea Goren | Chief Financial Officer | Appointed | 2021-06-15 |
| Debra Hoopes | acting Chief Financial Officer | Resigned | 2021-06-15 |
| Rebecca Messina | director | Appointed | 2021-04-26 |
| Jeffrey J. Segal, M.D. | director | Appointed | 2020-11-09 |
| Matthew Szot | director | Appointed | 2020-09-16 |
| Barbara Ryan | director | Appointed | 2020-09-16 |
| Michael Campbell | director | Resigned | 2020-09-16 |
| Kathleen Karloff | director | Resigned | 2020-09-16 |
Key facts
CIK
1417926
CUSIP
44984F880
13F (30d)
11 filings
11 filers
Visit website
Investor relations